Earnings Outlook For Novartis
Novartis (NYSE:NVS) is gearing up to announce its quarterly earnings on Thursday, 2025-07-17. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Novartis will report an earnings per share (EPS) of $2.38.
Anticipation surrounds Novartis's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
Earnings Track Record
During the last quarter, the company reported an EPS beat by $0.20, leading to a 0.04% increase in the share price on the subsequent day.
Here's a look at Novartis's past performance and the resulting price change:
| Quarter | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| EPS Estimate | 2.08 | 1.79 | 1.96 | 1.86 |
| EPS Actual | 2.28 | 1.98 | 2.06 | 1.97 |
| Price Change % | 0.0% | -0.0% | -1.0% | -1.0% |
Tracking Novartis's Stock Performance
Shares of Novartis were trading at $119.67 as of July 15. Over the last 52-week period, shares are up 10.56%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
To track all earnings releases for Novartis visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
